Evidence map›Paper›PMID 31555128›Full record

ReviewFrontiers in pharmacology2019

Considerations for an

Alexandre J S Ribeiro, Brian D Guth, Michael Engwall, Sandy Eldridge, C Michael Foley, Liang Guo, Gary Gintant, John Koerner, Stanley T Parish, Jennifer B Pierson and 4 more

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. mBio · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Emerging technologies and their impact on regulatory science.Experimental biology and medicine (Maywood, N.J.) · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Alexandre J S RibeiroDivision of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translation Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.
Brian D GuthDepartment of Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany.
Michael EngwallSafety Pharmacology and Animal Research Center, Amgen Research, Thousand Oaks, CA, United States.
Sandy EldridgeDivision of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
C Michael FoleyDepartment of Integrative Pharmacology, Integrated Sciences and Technology, AbbVie, North Chicago, IL, United States.
Liang GuoLaboratory of Investigative Toxicology, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
Gary GintantDepartment of Integrative Pharmacology, Integrated Sciences and Technology, AbbVie, North Chicago, IL, United States.
John KoernerDivision of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translation Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.
Stanley T ParishHealth and Environmental Sciences Institute, Washington, DC, United States.
Jennifer B PiersonHealth and Environmental Sciences Institute, Washington, DC, United States.
Mathew BrockDepartment of Safety Assessment, Genentech, South San Francisco, CA, United States.
Khuram W ChaudharyGlobal Safety Pharmacology, GlaxoSmithKline plc, Collegeville, PA, United States.
Yasunari KandaDivision of Pharmacology, National Institute of Health Sciences, Kanagawa, Japan.
Brian BerridgeNational Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Contractility of the myocardium engines the pumping function of the heart and is enabled by the collective contractile activity of its muscle cells: cardiomyocytes. The effects of drugs on the contractility of human cardiomyocytes

Indexed as

cellular alignmentco-cultureelectrical stimulationmicroenvironmentsarcomere

Identifiers

PMID31555128
PMCPMC6727630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.